Oral News and Research

RSS

People with CD36 gene may like high-fat foods more than others

A preference for fatty foods has a genetic basis, according to researchers, who discovered that people with certain forms of the CD36 gene may like high-fat foods more than those who have other forms of this gene.

3 Feb 2012

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCC

Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.

3 Feb 2012

House votes to repeal CLASS Act — A part of the 2010 health law

The GOP-led push to repeal this long-term care insurance program, which the Obama administration already made clear it would not implement, drew some Democratic votes. During floor speeches, Republican lawmakers cast it as a barrier to achieving a real reform.

3 Feb 2012

CSL Behring announces results of rIX-FP Phase I study on hemophilia B

CSL Behring today announced the results of a Phase I study evaluating recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP) in patients with severe hemophilia B.

3 Feb 2012

Cedars-Sinai experts to present research updates at International Stroke Conference

Stroke experts from Cedars-Sinai Medical Center will present research updates at the International Stroke Conference of the American Heart Association/American Stroke Association Feb. 1 through Feb. 3 in New Orleans.

3 Feb 2012

State roundup: Iowa Senate provides $5M for mental health; UMass health to cut 6% of workforce; Judge considers making Wash. pharmacies sell Plan B

The bill also allocates $5 million more from what is known as the Mental Health Risk Pool. The pool was created about a decade ago to keep counties with financial shortfalls from denying care to people with mental disorders or retardation. Linn County, for example, will receive $1.2 million of the extra money.

3 Feb 2012

Researchers identify fexinidazole as potential new therapy for visceral leishmaniasis

Researchers at the University of Dundee have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease visceral leishmaniasis.

3 Feb 2012

Pfizer recalls a million oral contraceptive pills

Pfizer has recalled 1 million packs of Lo/Ovral-28 and generic norgestrel/ethinyl estradiol birth control pills. These pills that need to be taken in the correct sequence have been mixed up in packaging and women using them could be at risk of pregnancy.

2 Feb 2012

Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin structure infections

Affinium Pharmaceuticals announced today dosing of the first patient in a multi-center Phase 2 clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure infections.

1 Feb 2012

AACS 2012 announces record attendance at annual scientific meeting

The American Academy of Cosmetic Surgery (AACS) announced its highest attendance in the Academy’s history with more than 700 medical professionals at its 28th Annual Scientific Meeting. The event was held January 18-21, 2012 at Caesars Palace Hotel in Las Vegas.

1 Feb 2012

State roundup: Iowa reconsiders lawmakers' benefits

Two bills introduced in the Iowa House last week would curtail benefits for lawmakers. ... House File 2118 also removes per diem and daily allowances from inclusion in lawmakers' pension calculations, but also requires members and employees of the General Assembly to pay a portion of their health-insurance premiums. That premium payment would have to be at least $100 a month.

1 Feb 2012

Nanosize titanates may inhibit growth of oral cancer and bacterial cell lines

Sometimes bigger isn't better. Researchers at the U.S. Department of Energy's Savannah River National Laboratory have successfully shown that they can replace useful little particles of monosodium titanate (MST) with even tinier nano-sized particles, making them even more useful for a variety of applications.

1 Feb 2012

Oral HPV infection more common in men than women: Study

According to a new US study, oral human papillomavirus (HPV) infection is more common among men than women, leading to an increased risk for men of head and neck cancers. HPV causes the majority of cervical cancers, as well as genital and anal - and head and neck cancers.

31 Jan 2012

Roche’s skin cancer drug Erivedge gets FDA nod

The Food and Drugs Administration (FDA) this Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.

31 Jan 2012

IFT's fifth Wellness conference to be held March 28-29, 2012

IFT will be hosting the fifth Wellness conference March 28th and 29th. The conference will offer attendees a unique blend of unbiased perspectives, news about emerging trends, and information on how organizations within the food industry are penetrating the health and wellness sector.

31 Jan 2012

Interim results from Allos Therapeutics' FOLOTYN and bexarotene Phase 1 combination study on CTCL

Allos Therapeutics, Inc. today reported interim results from the Company's ongoing Phase 1 combination study of FOLOTYN and bexarotene in patients with relapsed or refractory cutaneous T-cell lymphoma.

31 Jan 2012

Bioton and Actavis form joint venture

Actavis and Bioton announced today that they have formed a joint venture company for the development and registration of insulins, including analogue insulins.

31 Jan 2012

Humana creates new dental plan

Humana has created a new dental plan available to individuals - the HumanaOne Dental Loyalty Plus Plan - a product designed for people seeking coverage for preventive care and other services with the flexibility to choose the dentist they prefer.

31 Jan 2012

Obama administration lawyers file brief in support of health law

The Obama administration told the Supreme Court on Friday that nearly all of President Barack Obama's healthcare overhaul can survive if the court declares unconstitutional the law's centerpiece provision requiring health coverage. Administration attorneys argued in a written brief that all but two provisions can be separated from the requirement that Americans buy health insurance or pay a penalty by 2014, the law's cornerstone known as the individual mandate.

31 Jan 2012

AMAG completes enrollment in Feraheme Phase III program for iron-deficiency anemia

AMAG Pharmaceuticals, Inc. today announced the completion of patient enrollment in the second of the company's two phase III studies that comprise its global registrational program for Feraheme (ferumoxytol) in patients with iron-deficiency anemia (IDA) who are not candidates for oral iron, regardless of the underlying cause.

30 Jan 2012